Calliditas Therapeutics
CALTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010441584 (+1 more)
- LEI:
- 549300PVPZO8TNT76B58
- Country:
- Sweden
- Address:
- Box 70351, 107 24 Stockholm
- Website:
- https://www.calliditas.se/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Calliditas is dedicated to expanding treatment options and establishing new standards of care for people with rare diseases. By drawing on our expertise in pharmaceutical product development and leveraging our strategic partnerships, we quickly and efficiently identify, develop, and market a pipeline of innovative medicines that can improve the lives of patients. Recently, we successfully commercialized our lead candidate in the United States, and in collaboration with our partners, launched in Europe, with plans to seek approval in Asia.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2024-09-16 15:30 |
Delisting Announcement
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
|
English | 134.8 KB | |
2024-09-16 15:30 |
Delisting Announcement
Avnotering av Calliditas Therapeutics AB (publ) från Nasdaq Stockholm
|
Swedish | 134.6 KB | |
2024-08-13 07:00 |
Interim Report
|
Swedish | 2.0 MB | |
2024-08-13 07:00 |
Interim Report
|
English | 2.0 MB | |
2024-08-06 11:00 |
Major Shareholding Notification
|
English | 34.7 KB | |
2024-08-05 13:51 |
Major Shareholding Notification
|
English | 34.5 KB | |
2024-07-31 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Calliditas Therapeutics
|
Swedish | 180.0 KB | |
2024-07-31 14:00 |
Share Issue/Capital Change
Number of shares and votes in Calliditas Therapeutics
|
English | 120.7 KB | |
2024-07-26 08:00 |
Earnings Release
Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliar…
|
English | 219.4 KB | |
2024-07-26 08:00 |
Regulatory News Service
Calliditas utläser positiva topline-data från fas 2b-studien TRANSFORM i primär…
|
Swedish | 223.3 KB | |
2024-06-17 17:30 |
Post-Annual General Meeting Information
Kommuniké från årsstämman i Calliditas Therapeutics AB (publ)
|
Swedish | 158.0 KB | |
2024-06-17 17:30 |
Post-Annual General Meeting Information
Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
|
English | 141.0 KB | |
2024-06-04 10:15 |
Major Shareholding Notification
|
English | 34.1 KB | |
2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA får positivt yttrande från CHMP som rekommenderar ett …
|
Swedish | 176.3 KB | |
2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA receives positive CHMP opinion recommending full appro…
|
English | 177.8 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2022-12-20 | RENÉE AGUIAR LUCANDER | Other | Sell | 145,000 | 13,448,750.00 SEK |
2022-12-20 | Frank Bringstrup | Other | Other | 7,500 | 558,750.00 SEK |
2022-12-19 | Frank Bringstrup | Other | Sell | 5,500 | 532,400.00 SEK |
2022-08-17 | Elmar Schnee | Other | Other | 23,236 | N/A |
2022-08-16 | Diane Parks | Other | Other | 8,449 | N/A |
2022-08-12 | Hilde Furberg | Other | Other | 8,449 | N/A |
2022-05-27 | Henrik Stenqvist | Other | Buy | 5,000 | 445,000.00 SEK |
2022-03-24 | RENÉE AGUIAR LUCANDER | Other | Other | 175,000 | 13,002,500.00 SEK |
2022-03-24 | Frank Bringstrup | Other | Other | 6,000 | 445,800.00 SEK |
2022-03-24 | Andrew Udell | Other | Other | 26,000 | 1,931,800.00 SEK |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
Ananda Pharma Plc | United Kingdom | N/A | ||
![]() |
AnGes, Inc. | Japan | 4563 |